Healthcare · Medical Devices / Continuous Glucose Monitoring
Dexcom, Inc. is a global medical-device company specializing in the design, development, and commercialization of continuous glucose monitoring systems for diabetes and metabolic health. Its portfolio includes the G-series platforms, Dexcom ONE/ONE+, and Stelo, supported by direct, distributor, and digital channels across the United States and international markets.
Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.
Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.
Market information is supplied by TradingView and may be delayed or unavailable for certain exchanges or instruments. It does not constitute investment advice.